Determination of Apalutamide in Human Plasma by Sensitive LC‐MS/MS Method and the Application to a Bioequivalence Study
Year: 2026
Type: article
Abstract: A highly robust and high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay was developed and validated for the quantification of apalutamide in human plasma. Chromatographic separation was achieved on a ZORBAX Eclipse XDB-C18 column via gradient elution, using a mobile phase comprising acetonitrile and 0.1% formic acid with 5-mM ammonium acetate. The method featured a broad linear dynamic range of 1.00-2500 ng/mL. Furthermore, the assay exhibited exceptional selectivity and matrix resistance across normal, hyperlipidemic, and hemolyzed blank matrices. Validation results demonstrated high reliability: Intra-batch and inter-batch precision (CV) were ≤ 6.6%, with accuracies (RE) strictly within ±3.4%. Mean extraction recoveries for apalutamide and the internal standard exceeded 102%. This method was applied to evaluate the pharmacokinetics of a single 60-mg apalutamide dose in 60 healthy Chinese male volunteers under both fasting and fed conditions. The 90% confidence intervals for the geometric mean ratios of all primary pharmacokinetic parameters fell within the regulatory 80%-125% equivalence limits. Consequently, the test and reference formulations were confirmed to be bioequivalent. The 60-mg oral dosage was well tolerated by all subjects, with no serious adverse events or adverse events exceeding Grade 1 observed during the trial.
Source: Biomedical Chromatography
DOI: 10.1002/bmc.70667
Authors: Ting Lu, Dan Xiong, Zhao Yuan, Man Xu, Ming‐yi Liu
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: bronze
OpenAlex ID: W7235698792
